CRISPR Therapeutics AG (CRSP)
57.08
-2.42
(-4.08%)
USD |
NASDAQ |
Aug 24, 16:00
57.07
0.00 (0.00%)
After-Hours: 05:10
CRISPR Therapeutics Price : 57.08 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 58.75 | 58.96 | 56.62 | 57.08 | 1.120M |
| Aug 21, 2026 | 59.72 | 62.54 | 58.89 | 59.50 | 2.454M |
| Aug 20, 2026 | 58.73 | 60.90 | 56.94 | 58.12 | 2.910M |
| Aug 19, 2026 | 55.00 | 59.92 | 54.98 | 59.81 | 3.843M |
| Aug 18, 2026 | 53.20 | 53.88 | 51.80 | 52.97 | 1.314M |
| Aug 17, 2026 | 53.08 | 54.57 | 52.61 | 54.28 | 958154.0 |
| Aug 14, 2026 | 53.99 | 54.00 | 52.23 | 53.55 | 807993.0 |
| Aug 13, 2026 | 54.28 | 54.70 | 53.50 | 53.99 | 909129.0 |
| Aug 12, 2026 | 54.30 | 55.02 | 53.46 | 53.99 | 742904.0 |
| Aug 11, 2026 | 53.88 | 54.68 | 53.12 | 54.07 | 1.066M |
| Aug 10, 2026 | 53.50 | 54.68 | 53.10 | 53.51 | 1.187M |
| Aug 07, 2026 | 52.58 | 54.17 | 52.18 | 53.52 | 1.284M |
| Aug 06, 2026 | 52.55 | 53.11 | 51.51 | 51.64 | 1.026M |
| Aug 05, 2026 | 53.00 | 53.33 | 51.81 | 52.45 | 1.620M |
| Aug 04, 2026 | 50.55 | 53.20 | 50.16 | 53.07 | 2.143M |
| Aug 03, 2026 | 48.04 | 49.90 | 47.50 | 49.57 | 1.405M |
| Jul 31, 2026 | 48.54 | 49.03 | 47.31 | 47.99 | 1.036M |
| Jul 30, 2026 | 47.70 | 48.73 | 47.50 | 48.44 | 1.381M |
| Jul 29, 2026 | 47.42 | 48.15 | 46.82 | 47.64 | 1.895M |
| Jul 28, 2026 | 46.60 | 48.00 | 45.89 | 47.55 | 2.081M |
| Jul 27, 2026 | 47.66 | 48.28 | 46.71 | 46.73 | 1.335M |
| Jul 24, 2026 | 47.92 | 48.07 | 45.90 | 46.54 | 1.390M |
| Jul 23, 2026 | 47.00 | 48.35 | 46.46 | 47.53 | 1.713M |
| Jul 22, 2026 | 48.00 | 48.10 | 46.72 | 47.24 | 2.409M |
| Jul 21, 2026 | 46.99 | 48.62 | 46.86 | 48.15 | 1.384M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 547.59 |
| BeOne Medicines Ltd. | 371.98 |
| Basilea Pharmaceutica AG | 77.40 |
| Santhera Pharmaceuticals Holding AG | 23.25 |
| AC Immune SA | 2.86 |
Price Related Metrics
| PS Ratio | 403.96 |
| Price to Book Value | 3.159 |
| Earnings Yield | -8.34% |
| Market Cap | 5.517B |